SCHEMBL2872072

SCHEMBL2872072

CCCOC(=O)C[C@H](O)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
KEAP1 Q14145 1/20 0.40
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 4/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 3/20 0.39
POLB P06746 3/20 0.39
LMNA P02545 2/20 0.39
ADORA2B P29275 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
ALOX5 P09917 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP3 P42574 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871207 1.00 CES2 (0.40) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2871203 1.00 CES2 (0.40) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2869745 0.92 L3MBTL1 (0.45) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2867478 0.92 L3MBTL1 (0.45) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2867482 0.92 L3MBTL1 (0.45) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2859012 0.88 ALDH1A1 (0.43) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2859011 0.88 ALDH1A1 (0.43) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2867866 0.88 ALDH1A1 (0.43) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL5720919 0.84 ALDH1A1 (0.41) CES2CES1KEAP1ALDH1A1KMT2A
SCHEMBL2865878 0.82 ALDH1A1 (0.41) CES2CES1KEAP1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659409-B2 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-09 US disclosed
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2005-05-19 US disclosed
EP-1486493-A1 3-HYDROXY-3-(2-THIENYL)PROPIONAMIDE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING 3-AMINO-1-(2-THIENYL)-1-PROPANOL COMPOUND THEREFROM Mitsubishi Chemical Corporation (JP) 2004-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same APEH, AADAC, KMO CES2 719/4885CES1 126/4885KEAP1 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.